The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 15 Jul 2003
doi: 10.1242/jcs.00673
Research Article
Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the
5
1 integrin
Angela Orecchia*,
Pedro Miguel Lacal,
Cataldo Schietroma,
Veronica Morea,
Giovanna Zambruno,
and
Cristina Maria Failla
* Author for correspondence (e-mail: a.orecchia{at}idi.it)
Vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor for several growth factors of the VEGF family. Endothelial cells express a membrane-spanning form of VEGFR-1 and secrete a soluble variant of the receptor comprising only the extracellular region. The role of this variant has not yet been completely defined. In this study, we report that the secreted VEGFR-1 is present within the extracellular matrix deposited by endothelial cells in culture, suggesting a possible involvement in endothelial cell adhesion and migration. In adhesion assays, VEGFR-1 extracellular region specifically promoted endothelial cell attachment. VEGFR-1-mediated cell adhesion was divalent cation-dependent, and inhibited by antibodies directed against the
5
1 integrin. Moreover, VEGFR-1 promoted endothelial cell migration, and this effect was inhibited by anti-
5
1 antibodies. Direct binding of VEGFR-1 to the
5
1 integrin was also detected. Finally, binding to VEGFR-1 initiated endothelial cell spreading. Altogether these results indicate that the soluble VEGFR-1 secreted by endothelial cells becomes a matrix-associated protein that is able to interact with the
5
1 integrin, suggesting a new role of VEGFR-1 in angiogenesis, in addition to growth factor binding.
This article has been cited by other articles:

|
 |

|
 |
 
R. Silva, G. D'Amico, K. M. Hodivala-Dilke, and L. E. Reynolds
Integrins: The Keys to Unlocking Angiogenesis
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2008;
28(10):
1703 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Kappas, G. Zeng, J. C. Chappell, J. B. Kearney, S. Hazarika, K. G. Kallianos, C. Patterson, B. H. Annex, and V. L. Bautch
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
J. Cell Biol.,
May 28, 2008;
181(5):
847 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soro, A. Orecchia, L. Morbidelli, P. M. Lacal, V. Morea, K. Ballmer-Hofer, F. Ruffini, M. Ziche, S. D'Atri, G. Zambruno, et al.
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through {alpha}5{beta}1 integrin
Blood,
April 1, 2008;
111(7):
3479 - 3488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tian, C.-h. Zhu, X.-w. Zhang, X. Xie, X.-l. Xin, Y.-h. Yi, L.-p. Lin, M.-y. Geng, and J. Ding
Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and {alpha}vbeta3 Integrin via Binding to the Extracellular Domain of KDR
Mol. Pharmacol.,
September 1, 2007;
72(3):
545 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pillozzi, M. F. Brizzi, P. A. Bernabei, B. Bartolozzi, R. Caporale, V. Basile, V. Boddi, L. Pegoraro, A. Becchetti, and A. Arcangeli
VEGFR-1 (FLT-1), {beta}1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome
Blood,
August 15, 2007;
110(4):
1238 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D'Arcangelo, V. Ambrosino, M. Giannuzzo, C. Gaetano, and M. C. Capogrossi
Axl receptor activation mediates laminar shear stress anti-apoptotic effects in human endothelial cells
Cardiovasc Res,
September 1, 2006;
71(4):
754 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Marcellini, N. De Luca, T. Riccioni, A. Ciucci, A. Orecchia, P. M. Lacal, F. Ruffini, M. Pesce, F. Cianfarani, G. Zambruno, et al.
Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor
Am. J. Pathol.,
August 1, 2006;
169(2):
643 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Das, H. Yeger, R. Tsuchida, R. Torkin, M. F.W. Gee, P. S. Thorner, M. Shibuya, D. Malkin, and S. Baruchel
A Hypoxia-Driven Vascular Endothelial Growth Factor/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1{alpha} through Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 Pathway in Neuroblastoma
Cancer Res.,
August 15, 2005;
65(16):
7267 - 7275.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003